Calcipotriene

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

39 Suppliers, 21 USDMF, 10 CEP/COS, 1 EU WC, 1 KDMF, 14 NDC API, 20 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

97 Dossiers, 23 FDA Orange Book, 38 Europe, 23 Canada, 1 Australia, 7 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.005%, SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%, AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

Suppliers, 12 BASF, 4 Nanjing Well Pharmaceutical, 3 Actylis, 2 Finar, 1 Kerry, 1 Seppic, 1 Alcedo Pharmachem, 1 Corel Pharma Chem

EXCIPIENTS BY APPLICATIONS

14 Topical, 5 Parenteral, 5 Solubilizers, 4 Lubricants & Glidants, 4 Thickeners and Stabilizers, 3 Controlled & Modified Release, 3 Film Formers & Plasticizers, 3 Emulsifying Agents, 2 Granulation, 2 Direct Compression, 1 Fillers, Diluents & Binders, 1 Coating Systems & Additives

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 37 Finished Drug Prices

MARKET PLACE

9 APIs, 1 DOSSIERS // FDF

PATENTS

18 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 1 Others

DIGITAL CONTENT

27 News

27 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing Calcipotriene. Original Data : Therapeutic Goods Administration Website

Calcipotriene

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

39 Suppliers

21 USDMF

10 CEP/COS

1 EU WC

1 KDMF

14 NDC API

20 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

97 Dossiers

23 FDA Orange Book

38 Europe

23 Canada

1 Australia

7 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.005%

SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

Suppliers

12 BASF

4 Nanjing Well Pharmaceutical

3 Actylis

2 Finar

1 Kerry

1 Seppic

1 Alcedo Pharmachem

1 Corel Pharma Chem

EXCIPIENTS BY APPLICATIONS

14 Topical

5 Parenteral

5 Solubilizers

4 Lubricants & Glidants

4 Thickeners and Stabilizers

3 Controlled & Modified Release

3 Film Formers & Plasticizers

3 Emulsifying Agents

2 Granulation

2 Direct Compression

1 Fillers, Diluents & Binders

1 Coating Systems & Additives

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

37 Finished Drug Prices

MARKET PLACE

9 APIs

1 DOSSIERS // FDF

PATENTS

18 US Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

2 USP

1 Others

DIGITAL CONTENT

27 News

Calcipotriene

Sandoz B2B

Calcipotriol; Betamethasone Dipropionate

Ointment; Ointment

0.005%; 0.05%

Calcipotriol/Betamethasone Sandoz

1

SOLUTION;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons